Lyka Labs Limited Share Price and Company Fundamentals

0.400 (0.299%)
52 week
102.1 - 267.0

Last traded: Today at 10:00 AM

Lyka Labs Limited, a pharmaceutical company, engages in development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, muscle relaxant, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia, as well as deals in pharmaceutical products. The company offers its products in various formulations, including injections, creams, ointments, gels, and lotions. It also exports its products to Bangladesh, Combodia, Congo, Costa Rica, Peru, Romania, Russia, Sri Lanka, Sudan, Ukraine, Venezuela, and Vietnam. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India.

Key Metrics

PE ratio


PB ratio


Dividend yield




Market cap


Enterprise value


Company profile

Industry / Sector Biotechnology / Healthcare
Full time employees 164
Mailing address Spencer Building Ground Floor 30, Forjett Street Grant Road (West) Mumbai 400036 India
Phone / Fax 91 22 6611 2200 / 91 22 6611 2248


Dividend yield


Dividend amount


Payout ratio


Lyka Labs Limited paid ₹0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.LYKALABS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

LYKALABS's forward dividend amount is ₹ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Dec 2022, following are the company executives and directors listed on Lyka Labs Limited.

Name Title Age Total Pay
Mr. Kunal Narendra Gandhi MD, CEO & Director 34 8.94M
Mr. Yogesh Babulal Shah CFO & Exec. Director 61 1.42M
Mr. Kishore P. Shah Company Sec. & Compliance Officer
Mr. B. S. Arun Rao CEO of Lyka BDR International Ltd and Whole-Time Director of Lyka BDR International Ltd

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Lyka Labs Limited is and its enterprise value is .

The LYKALABS's stocks Beta value is 1.07 making it 7% more volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Lyka Labs Limited (NSE:LYKALABS) Frequently Asked Questions

1. What is Lyka Labs Limited's Stock Symbol?

Lyka Labs Limited trades on NSE under the ticker symbol "LYKALABS".

2. What is Lyka Labs Limited's stock price today?

One share of LYKALABS stock can currently be purchased for approximately ₹134.15.

3. How can I contact Lyka Labs Limited?

Lyka Labs Limited's mailing address is Spencer Building Ground Floor 30, Forjett Street Grant Road (West) Mumbai 400036 India. The company can be reached via phone at 91 22 6611 2200.

4. What is Lyka Labs Limited's official website?

The official website of Lyka Labs Limited is